Pharming Group N.V.

Pharming Group N.V.verified




Market Cap:


Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The com...[Read more]



IPO Date


Stock Exchange




The PE Ratio as of June 2024 (TTM) for Pharming Group N.V. (PHARM.AS) is -74.30

According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -74.30. This represents a change of -321.66% compared to the average of 33.52 of the last 4 quarters.

Pharming Group N.V. (PHARM.AS) Historical PE Ratio (quarterly & annually)

How has PHARM.AS PE Ratio performed in the past?

The mean historical PE Ratio of Pharming Group N.V. over the last ten years is 3.63. The current -74.30 PE Ratio has changed -204651.79% with respect to the historical average. Over the past ten years (40 quarters), PHARM.AS's PE Ratio was at its highest in in the June 2023 quarter at 148.69. The PE Ratio was at its lowest in in the September 2021 quarter at -192.78.

Quarterly (TTM)









Pharming Group N.V. (PHARM.AS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharming Group N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.39%

Maximum Annual PE Ratio = 55.02

Minimum Annual Increase = -371.85%

Minimum Annual PE Ratio = -69.36

Quarterly (TTM)
YearPE RatioChange

Pharming Group N.V. (PHARM.AS) Average PE Ratio

How has PHARM.AS PE Ratio performed in the past?

The current PE Ratio of Pharming Group N.V. (PHARM.AS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Pharming Group N.V. (PHARM.AS) PE Ratio vs. Peers

How is PHARM.AS’s PE Ratio compared to its peers?

Pharming Group N.V.’s PE Ratio is less than Galapagos NV (5.63), less than Koninklijke BAM Groep nv (3.93), less than Fugro N.V. (6.47), less than PostNL N.V. (21.98), less than AMG Advanced Metallurgical Group N.V. (20.54),

Build a custom stock screener for Pharming Group N.V. (PHARM.AS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharming Group N.V. (PHARM.AS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pharming Group N.V.'s PE Ratio?

How is the PE Ratio calculated for Pharming Group N.V. (PHARM.AS)?

What is the highest PE Ratio for Pharming Group N.V. (PHARM.AS)?

What is the 3-year average PE Ratio for Pharming Group N.V. (PHARM.AS)?

What is the 5-year average PE Ratio for Pharming Group N.V. (PHARM.AS)?

How does the current PE Ratio for Pharming Group N.V. (PHARM.AS) compare to its historical average?